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Background—To facilitate the optimal timing of pulmonary valve replacement, we analyzed preoperative thresholds of
right ventricular (RV) volumes above which no decrease or normalization of RV size takes place after surgery.
Methods and Results—Between 1993 and 2006, 71 adult patients with corrected tetralogy of Fallot underwent pulmonary
valve replacement in a nationwide, prospective follow-up study. Patients were evaluated with cardiovascular magnetic
resonance both preoperatively and postoperatively. Changes in RV volumes were expressed as relative change from
baseline. RV volumes decreased with a mean of 28%. RV ejection fraction did not change significantly after surgery
(from 4210% to 4310%; P0.34). Concomitant RV outflow tract reduction resulted in a 25% larger decrease of RV
volumes. After correction for surgical RV outflow tract reduction, higher preoperative RV volumes (mL/m2) were
independently associated with a larger decrease of RV volumes (RV end-diastolic volume: 0.41; P0.001). Receiver
operating characteristic analysis revealed a cutoff value of 160 mL/m2 for normalization of RV end-diastolic volume or
82 mL/m2 for RV end-systolic volume.
Conclusions—Overall, we could not find a threshold above which RV volumes did not decrease after surgery. Preoperative
RV volumes were independently associated with RV remodeling and also when corrected for a surgical reduction of the
RV outflow tract. However, normalization could be achieved when preoperative RV end-diastolic volume was 160
mL/m2 or RV end-systolic volume was 82 mL/m2. (Circulation. 2007;116:545-551.)
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In patients with corrected tetralogy of Fallot and residuallong-standing pulmonary regurgitation, timing of pulmo-
nary valve replacement (PVR) remains controversial.1,2 Ben-
eficial effects of PVR have to be weighed against the risk for
repeat PVR.3,4 Beneficial effects of PVR include improve-
ment in functional class and exercise capacity, reduction of
right ventricular (RV) size,2 and decrease in QRS duration.5
Because data on long-term morbidity and mortality are
lacking on this subject, cardiovascular magnetic resonance
(CMR) can be used to accurately assess the effect of PVR on
RV volumes and function. Although PVR may result in a
decrease in RV volumes,2,5 it remains unknown whether a
threshold can be found above which no RV remodeling
occurs after PVR. Furthermore, it remains a subject of debate
whether RV remodeling is the result of the intrinsic capacity
of the RV or is largely dependent on surgically reducing the
RV outflow tract (RVOT). Some reports have assessed the
effects of PVR by examining normalization of RV volumes
after surgery but only with a limited number of patients.5,6
Therefore, in a prospective, multicenter study we analyzed
whether a threshold exists above which the RV does not
improve further after surgery and whether preoperative
thresholds can be identified for normalization of RV volumes
after surgery.
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Methods
Patient Population
In a nationwide, prospective study, 71 patients with a previous
correction for tetralogy of Fallot were followed up after PVR. Patient
characteristics are listed in Table 1. Data on the first 25 patients, who
were operated on between 1993 and 2002, were reported previously.2
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The remaining patients were operated on between 2002 and 2006 in
5 tertiary referral centers. CMR was performed preoperatively and 6
to 12 months postoperatively following clinical protocol. After the
first year, patients were routinely followed up at the outpatient
clinics of the participating centers, according to their local protocols.
The medical records for all patients were reviewed. Data collected
included patient characteristics, operations and concomitant proce-
dures, echocardiographies, and ECGs. The international research
boards approved the study, and informed consent was obtained in all
patients.
Guidelines for replacing the pulmonary valve in patients with
severe pulmonary regurgitation included progressive RV enlarge-
ment, progressive tricuspid regurgitation, arrhythmias, or symptoms
such as deteriorating exercise performance.7 The exact interpretation
of these guidelines was left to the participating centers.
Pulmonary Valve Replacement
All homografts were allocated by Bio Implant Services, Leiden, the
Netherlands, from whom the data on homograft and donor charac-
teristics were obtained. Additional procedures performed at the time
of PVR are listed in Table 1. All patients were operated on with
normothermic or moderately hypothermic cardiopulmonary bypass.
Most pulmonary valve insertions were performed on beating hearts.
Aortic cross-clamping was dependent on the surgeon’s preference or
on concomitant procedures. Arrhythmia surgery was not performed
concomitantly. Cryopreserved pulmonary homografts were used for
most RVOT reconstructions. Homografts were inserted in the ortho-
topic pulmonary position with 1 proximal and 1 distal end-to-end
running suture after longitudinally opening the proximal pulmonary
artery and slightly extending this incision if necessary across the
former pulmonary annulus. The outflow tract patch material was
resected as much as possible. Although the patch resection itself may
decrease RVOT size, this procedure was performed in all patients,
and information on the size of the resected material was not available
to us. Therefore, we considered the RVOT surgically reduced when
the RVOT proximal to the graft was reduced to overcome the size
discrepancy with the pulmonary homograft. We expected that the
reduction in RV size would be greatest in this situation. The
indication for this procedure was left to the cardiac surgeon during
the procedure.
Cardiovascular Magnetic Resonance
CMR data were acquired on local available magnetic resonance
systems. Imaging sequences of the first 25 patients were previously
reported.2 For the remaining patients, CMR studies were performed
with the use of local imaging protocols.8 CMR was performed at a
median of 5 (3.4 to 7.6) months before and a median of 9 (6.2 to 15)
months after PVR. Scout images were obtained in 3 orthogonal
planes, and standard 2- and 4-chamber views were acquired. From
these views, a stack of 12 to 14 slices was acquired in the short-axis
orientation (steady state free precession). Images were analyzed at
the Leiden University Medical Center with standardized analysis
techniques.8 The short-axis orientation was used to calculate both
RV and left ventricular (LV) volumes from endocardial contours
with the use of MASS software (Medis, Leiden, the Netherlands).
Stroke volume (SV) was calculated by deducting the end-systolic
volume (ESV) from the end-diastolic volume (EDV), and ejection
fraction (EF) was defined as (SV100)/EDV. All volumes were
indexed for body surface area.
Velocity mapping was performed with the use of velocity-encoded
phase contrast sequence.8 For velocity mapping of the pulmonary
artery, sagittal and coronal scout images were used to construct a
double oblique plane perpendicular to the vessel. FLOW software
(Medis) was used to calculate regurgitant flow and systolic forward
flow. Pulmonary regurgitation was calculated as regurgitant
flow100/systolic forward flow.
Statistical Analysis
Data are described as frequency, mean with SD, or median with
interquartile range. Differences between parameters before and after
surgery were analyzed with paired Student t test, Wilcoxon signed
rank test, or McNemar test. Changes in CMR-derived ventricular
volumes after surgery were expressed as percent change from
baseline. One patient had 2 PVRs included in the analysis. Univariate
predictors for change in hemodynamic parameters after surgery
(patient characteristics [sex, age at repair, previous palliation, time
from repair to PVR], surgical characteristics [age at PVR, homograft
diameter, concomitant procedures], and CMR parameters at base-
line) were analyzed with independent Student t test, ANOVA, or
Pearson correlation coefficient, when appropriate. Independent pre-
dictors for change in hemodynamic parameters were analyzed with
multivariable linear regression analysis. All significant predictors in
univariate analysis entered the multivariable regression model with
the use of forward stepwise analysis. The identification of a
preoperative threshold in RV EDV index (EDVI) for normalization
of RV EDVI (108 mL/m2) and RV ESV index (ESVI) (47
mL/m2)9 was analyzed with the use of receiver operating character-
istic curves. We considered situations in which surgery was per-
formed “too early” (performing surgery when preoperative RV
volumes were low and did normalize after surgery; low specificity)
or “too late” (performing surgery when preoperative RV volumes
were high and did not normalize after surgery; low sensitivity)
equally adverse. Therefore, we selected the point at which sensitivity
and specificity were equal. A probability value of 0.05 was
considered statistically significant.
The authors had full access to and take full responsibility for the
integrity of the data. All authors have read and agree to the
manuscript as written.
TABLE 1. Patient and Surgical Characteristics
Variable
Male/female, n 42/29
Shunt procedure 41
Age at shunt procedure, y, median (IQR) 2.1 (0.8 to 3.8)
Age at initial repair (n66), y, median (IQR) 5.0 (2.7 to 7.4)
Type of initial repair (n66)
Myectomy/valvulotomy 14
RV patch 16
Transannular patch 69
RV to pulmonary artery conduit 1
Indications for PVR (all patients had moderate to severe
pulmonary regurgitation)
Symptomatic 71
Asymptomatic with progressive RV dilatation 24
Ventricular arrhythmias or QRS 180 ms 15
Progressive tricuspid regurgitation 4
Age at PVR, y, median (IQR) 29 (23 to 37)
Previous PVR 6
Diameter homograft, mm, meanSD 251.7
Type of graft for RVOT reconstruction
Pulmonary homograft 96
Contegra conduit 3
Aorta homograft 1
Concomitant procedures
Tricuspid valve plasty or ring 24
RV reduction plasty 18
Pulmonary artery angioplasty 15
Ventricular septal defect closure 4
Data are expressed as percentages unless otherwise noted. IQR indicates
interquartile range.
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Results
Clinical Events After Surgery
Clinical characteristics of all patients are listed in Table 1.
Median follow-up time after surgery was 1.6 (0.9 to 5.2)
years. Of the 71 patients prospectively followed up, 1 patient
died suddenly 18 months after PVR (age 33 years, no
preoperative arrhythmias, latest QRS duration 156 ms). Ten
months before his death, the patient underwent CMR with RV
EDVI of 133 mL/m2 and RV EF 30%. In 1 patient, implant-
able cardioverter-defibrillator implantation was planned 1
week postoperatively because of ventricular arrhythmias
before surgery and QRS duration of 192 ms (age 37 years,
preoperative RV EDVI 210 mL/m2, and RV EF 35%). One
patient developed sustained ventricular tachycardias after
PVR, which were hemodynamically tolerated, and underwent
radiofrequency ablation (age 35 years, no preoperative ar-
rhythmias, latest QRS duration 158 ms, preoperative RV
EDVI 175 mL/m2, and RV EF 49%). This patient refused to
undergo follow-up CMR. All of these patients were in New
York Heart Association class I or II.
Three patients underwent a second PVR. Two of these
patients underwent redo surgery 6 months after PVR
because of kinking of the (long) pulmonary homograft in one
and a false aneurysm with severe subvalvular stenosis in the
other. These patients underwent their follow-up CMR after
their second PVR. The remaining patient underwent redo
PVR 2 years after the first PVR because of no improvement
in RV volumes and validity class and significant residual
pulmonary regurgitation after the first surgery. During the
second PVR, the RVOT was reduced, and hemodynamics and
validity improved. Both PVRs of this patient were included in
the analysis. In total, 70 PVRs were available for analysis
with CMR (Figure 1). The characteristics and indications of
these PVRs are listed in Table 1.
Hemodynamic Changes After PVR
Changes in hemodynamics after PVR are listed in Table 2. In
Table 2, a reduction in RV volumes and QRS duration can be
observed as well as an increase in LV EDVI, net forward
flow, and validity class. No improvement in RV volumes was
observed in 4 patients. In 3 of these patients, residual
pulmonary regurgitation (20%) was observed, in 1 patient
as a result of low-grade endocarditis. None of the 4 patients
underwent a reduction of the RVOT. Individual lines for
absolute change in RV EDVI are depicted for patients who
did and did not undergo surgical RVOT reduction in Figure 2.
Relative decrease in RV EDVI was higher in patients under-
going surgical RVOT reduction compared with those who did
not (358% versus 2720%; P0.02). However, in patients
not undergoing surgical RV reduction, RV EDVI could still
decrease substantially when no residual pulmonary regurgi-
tation was present (Figure 2).
Figure 1. A still-frame image of
4-chamber cine imaging from CMR
(steady state free precession) is shown;
left, before PVR; right, after surgery.
Note the severely enlarged RV before
surgery and the reduction in RV volume
after surgery, with a consequent small
increase in LV size.
TABLE 2. Hemodynamic Changes After Surgery
Variable Before Surgery After Surgery Mean Difference Percent Change
RV EDVI, mL/m2 17144 11934* 5237 2819
RV ESVI, mL/m2 10238 7029* 3228 2731
RV SV index, mL/m2 7016 4910* 2115 2817
RV EF, % 4210 4310 1.08.7 4.722
RV corrected EF, % 248.1 4111* 1712 8764
LV EDVI, mL/m2 8522 9420* 8.320 1743
LV EF, % 529 538 1.17.4 4.015
Pulmonary regurgitant fraction, % 4413 59* 3917 9017
Net forward flow, mL/m2 3816 4612* 7.319 3447
Tricuspid regurgitation grade 2, % 26 19 . . . . . .
QRS duration, ms 15529 14429* 1111 7.06.1
NYHA class II, % 53 11* . . . . . .
Values are expressed as meanSD unless otherwise noted. NYHA indicates New York Heart Association.
*Statistically significant difference compared with baseline (P0.05).
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Predictors for Hemodynamic Improvement
After PVR
Decrease in RV volumes (RV EDVI and RV ESVI) was
related to preoperative values, and a threshold above which
RV did not decrease after PVR could not be observed (Figure
3). When the change in RV volumes was expressed as a
relative change from baseline, average decrease in both RV
EDVI and RV ESVI was 28% (Table 2). Although RV
volumes changed substantially, RV EF did not change sig-
nificantly. However, net SV and LV EDV improved after
surgery. Table 3 depicts preoperative predictors that were
multivariably associated with relative change in RV volumes
after surgery. Patients with a surgical reduction of the RVOT
had higher preoperative RV EDVI than patients without
surgical reduction (19853 versus 16539 mL/m2; P0.01).
After correction for a surgical reduction of the RVOT in a
multivariable model, relative change in RV EDVI and RV
ESVI remained independently associated with preoperative
RV EDVI (0.39, P0.001; 0.43, P0.001, respec-
tively). Interestingly, we observed that lower preoperative
RV EF resulted in a greater increase in RV EF after surgery
(Table 3) and a smaller LV EDVI resulted in a greater
increase in LV EDVI after surgery.
When postoperative predictors for change in RV EDVI (%)
are taken into account, postoperative pulmonary regurgitation
(%) entered the model as well (0.50 [SE 0.09],
P0.001). Decrease in RV EDVI (%) was related to both
increase in RV EF (R0.42, P0.001) and increase in LV
EDVI (R0.30, P0.012) and LV EF (R0.35, P0.001).
Cutoff Values for Normalization of RV EDVI and
RV ESVI
In 37% of the patients RV EDVI returned to normal values
(108 mL/m2), and in 17% RV ESVI returned to normal
values (47 mL/m2). Sensitivity and specificity for normal-
ization of RV EDVI were 55% and 92%, with a preoperative
RV EDVI cutoff value of 160 mL/m2 (Figure 4A). At 120
mL/m2, all patients normalized, and at 190 mL/m2, none of
the patients normalized after surgery. For normalization of
RV ESVI, a preoperative cutoff value of 82 mL/m2 was
observed, with a sensitivity of 74% and a specificity of 82%
(Figure 4B). Patients with normalization of RV EDVI and RV
ESVI after surgery had a lower postoperative QRS duration
(13330 versus 15226 ms; P0.02) and a higher postop-
erative RV EF (489.9% versus 408.8%; P0.001) than
patients with no normalization, respectively. No significant
difference in New York Heart Association class after surgery
was observed between patients with or without normalization
(1.30.36 versus 1.20.33, respectively; P0.31)
Discussion
In our study on optimal timing of PVR in patients with
corrected tetralogy of Fallot, we could not find a threshold
above which RV volumes did not decrease after surgery.
Preoperative RV volumes were independently associated
with RV remodeling and also when corrected for a surgical
reduction of the RVOT. Despite the substantial decrease in
patients with very high preoperative RV volumes, normaliza-
tion could be achieved when preoperative RV EDV was
160 mL/m2 or RV ESV was 82 mL/m2.
Improvement of RV Size and Function After PVR
After the disappointing results of PVR reported by Therrien
et al in 2001,1 several reports have shown beneficial effects of
PVR,2,6 including a report by Therrien et al as well,5 all using
CMR to quantify RV dimensions. In this report, we confirm
the decrease in RV volumes of 30% and an increase in
Figure 3. The association with preopera-
tive RV EDVI (A) or RV ESVI (B) and the
absolute decrease in RV volumes after
surgery is depicted (dashed line is the
regression line). Note that a threshold for
reduction in RV volumes after surgery
could not be identified. Individuals on the
left side of the solid line are patients in
whom ventricular volume returned to
normal after surgery. The vertical dashed
line represents the preoperative cutoff
value for normalization after surgery.
Figure 2. The actual decrease in RV EDV is depicted for patients in the present study. Left, Patients who did not undergo a surgical RVOT
reduction (n58); right, patients with a surgical RVOT reduction (n13). In 4 patients without surgical RVOT reduction, RV size did not
decrease after surgery. Three of these patients developed postoperative pulmonary regurgitation 20%. Note that in patients without
surgical RVOT reduction and high RV EDV, RV size could decrease substantially. Furthermore, 2 patients were operated on with normal
preoperative RV EDVI. Both patients became symptomatic with severe pulmonary regurgitation and a RV that was larger than the LV.
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effective SV of both ventricles.2,5,6 Besides these beneficial
effects of PVR on RV size and effective SV, we confirm an
overall improvement in functional New York Heart Associ-
ation class.10 RV function did not change after surgery, but it
remains unknown whether RV function stabilizes after sur-
gery or declines steadily over time, as is the case before PVR.
After the report by Vliegen et al,2 an important issue was
the question of whether the reported decrease in RV dilatation
after surgery was only the result of the surgical reduction of
the RV. In this report, we have shown that in patients with no
surgical reduction of the RV during PVR, reduction of RV
volumes may take place as well. Although most patients
underwent resection of the transannular patch, it seems
unlikely that placing a homograft over the defect without
additionally tailoring the RVOT results in a large additional
reduction in RV size. Furthermore, in the multivariable model
for decrease in RV volumes, only preoperative dilatation
remained significant in the model. We think that it is
important to perform a surgical reduction of the RVOT in
severely dilated RVOTs to prevent postoperative pulmonary
regurgitation.
In patients with tetralogy of Fallot, RV dysfunction may
negatively affect LV function.11 Geva et al12 emphasized that
LV function plays an important role in the patient’s func-
tional class. Interestingly, our study confirms a right-to-left
ventricular interaction after surgery. We observed that change
in RV volumes after surgery related directly to changes in LV
volumes and function. In our opinion, changes in RV vol-
umes are the most important benefit of PVR, and changes in
patient’s functional class, LV function, and QRS duration are
secondary to changes in RV volumes. Therefore, the main
focus of our report is the change in RV volumes after surgery.
Can We Operate Too Late?
Our study population consisted of patients from both centers
that are considered “conservative” in timing of PVR and
centers that advocate “early” PVR.2 Of interest is that in our
study, factors associated with delaying surgery (age at PVR,
time from initial repair to PVR, high RV EDVI) were not
associated with less decrease in RV volumes. Moreover,
patients with higher RV EDVI before surgery showed a
higher relative decrease in RV EDVI and RV ESVI. We
could not find a threshold above which RV volumes do not
decrease after surgery. Only patients with postoperative
pulmonary regurgitation showed no decrease in RV volumes
after surgery.13 Possibly, the difference between our study
and the study from Therrien et al,1 in which no change in RV
volumes was observed, is the use of CMR in our study versus
the use of radionuclide angiography, which is considered less
accurate in quantifying RV dimensions. Our results suggest
TABLE 3. Univariable Predictors for Hemodynamic Change After Surgery in
Multivariable Analysis
Parameter Predictor  (SE) P
RV EDVI decrease (%) Presurgery RV EDVI (mL/m2) 0.41 (0.11) 0.001
Surgical RV reduction (yes, no) 0.06 (0.12) 0.58
RV ESVI decrease (%) Presurgery RV EDVI (mL/m2) 0.39 (0.12) 0.001
RV EF increase (%) Presurgery RV EF (%) 0.64 (0.19) 0.001
Presurgery RV ESVI (mL/m2) 0.23 (0.19) 0.23
LV EDVI increase (%) Presurgery LV EDVI (mL/m2) 0.44 (0.11) 0.001
LV EF increase (%) Presurgery LV EF (%) 0.47 (0.12) 0.001
Presurgery RV EDVI (mL/m2) 0.10 (0.12) 0.39
Age at PVR (y) 0.14 (0.11) 0.21
Graft diameter (mm) 0.09 (0.11) 0.41
NYHA class improvement (%) Presurgery NYHA class (I–IV) 0.71 (0.09) 0.001
NYHA indicates New York Heart Association.
Figure 4. Receiver operating characteristic
curves are depicted for normalization of RV
EDVI (A) and RV ESVI (B) after PVR.
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that PVR substantially reduced RV dilatation, even in patients
with very high RV volumes and RV dysfunction.
Delaying PVR
The risk of “late” PVR includes irreversible RV dysfunction
after PVR. The risk of timing of early PVR in asymptomatic
patients primarily comprises the need for repeat PVR. In our
study, homografts were primarily used for RVOT reconstruc-
tion, and we have shown in a previous study that on average
a homograft is replaced 10 to 20 years after PVR.3 As long as
an ideal graft is yet to be found, delaying surgery has
substantial benefits.
However, despite the ability of the RV to reduce dilatation
substantially when preoperative RV volumes are high, not
many patients showed normalized RV volumes after surgery
(normalized RV EDVI in 37% and normalized RV ESVI in
17%). One might speculate that the RV improves further after
the 9 months in the present study. However, in a report by van
Straten et al,13 RV EDVI decreased only 1.8 mL/m2 from 7 to
18 months after PVR.
Because it is not yet known whether reducing the size of
the RV is enough to improve long-term outcomes after PVR,
it is not clear whether delaying PVR is a good approach.
Possibly, achieving normalization in RV volumes is impor-
tant in improving long-term outcomes. When the latter is
assumed, patients should be operated on before the RV EDVI
reaches 160 mL/m2 or RV ESVI reaches 82 mL/m2. Our
cutoff value of 160 mL/m2 for RV EDVI lies slightly below
the reported values by Therrien et al5 in adults (170 mL/m2)
and Buechel et al6 in children (200 mL/m2).
Other Factors Influencing Optimal Timing of PVR
Associated factors may alter the timing of PVR. Patients with
long-standing pulmonary regurgitation with subsequent RV
dilatation and severe ventricular arrhythmias should be eval-
uated for PVR. Risk for these ventricular arrhythmias is
higher when QRS duration is 180 ms.14 It has been
observed that QRS duration decreases after PVR, related to
the reduction in RV volumes.15 Ventricular arrhythmias or
sudden cardiac death occurred in 3 of 71 (4%) of the patients.
In a recent study, we observed that when patients were
operated on when QRS was 180 ms, the risk for ventricular
arrhythmias remained high (25%).16 In our opinion, PVR
should be performed before the QRS duration reaches 180 ms.
In some of the participating centers, PVR is delayed until
the patient becomes symptomatic. We have observed that
patients with high preoperative New York Heart Association
class showed an improvement in validity class after surgery.
However, some patients with severely dilated RVs were not
symptomatic in our study, and these patients were at in-
creased risk for increased RV volumes and reduced RV EF
after surgery. However, from our report, we cannot conclude
that delaying surgery until symptoms occur is unfavorable
because the long-term outcomes of increased RV volumes
and decreased RV EF after surgery are not known to us.
Other factors influencing timing of PVR include the
occurrence of significant hemodynamic abnormalities requir-
ing surgery: tricuspid regurgitation, residual ventricular septal
defect, and pulmonary stenosis. When 1 of these lesions is
present, PVR can be considered before the RV reaches the
preoperative cutoff values.
Limitations
Although, in our opinion, the patient population in the present
study reflects the wide clinical spectrum normally seen in
clinical practice, the present study lacks sufficient statistical
power to determine with confidence that there is no ceiling
effect, particularly in the range of very large RV EDVI (eg,
220 mL/m2). Future studies should incorporate data on hard
outcome variables, acquired during a longer follow-up pe-
riod, and use objective assessment of functional outcome to
make definitive conclusions on the effectiveness and indica-
tions for PVR.
We used a standard gradient echo imaging technique for
the first 25 previously described patients, whereas the subse-
quent patients were imaged with a steady state free precession
technique. These 2 techniques have been shown not to yield
equivalent results.17 However, baseline measurements and
measurements after PVR were performed with the same
imaging technique in all individual patients. Therefore, dif-
ferences before and after surgery could be assessed reliably.
Conclusion
Even in patients with very high preoperative RV volumes and
RV dysfunction, our results suggest that PVR substantially
reduced RV dilatation. A threshold could not be observed,
and RV size before surgery was independently associated
with reduction in RV volumes after surgery. A reduction of
RV volumes to normal values could be achieved when PVR
was performed before RV EDV reached 160 mL/m2 or RV
ESV reached 82 mL/m2.
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CLINICAL PERSPECTIVE
Patients with corrected tetralogy of Fallot and residual long-standing pulmonary regurgitation are at risk for heart failure
and sudden cardiac death. With pulmonary valve replacement, pulmonary regurgitation is targeted, and right ventricular
volume decreases after surgery. However, once a graft is placed in the pulmonary position, the patient will need to undergo
future redo surgery for graft failure. Controversy remains regarding the optimal timing of pulmonary valve replacement.
How long can pulmonary valve replacement be delayed, and above which right ventricular dimensions does remodeling
not occur after surgery? We analyzed preoperative and postoperative right ventricular volumes and function in 71 adult
patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. We observed that even in patients with
very severe preoperative right ventricular dilatation and dysfunction, pulmonary valve replacement substantially reduced
right ventricular dilatation. A threshold for remodeling after surgery could not be observed. Although greater right
ventricular dilation was associated with a greater reduction in right ventricular size, “normalization” of the right ventricle
occurred in only 37% of the patients. A substantial decrease in right ventricular size can still be obtained when surgery is
delayed until the right ventricle becomes severely dilated. However, when normalization in right ventricular size is
achieved, surgery should be performed at an earlier stage.
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